Financial Architects (New Jersey)’s Filana Therapeutics FLNA Stock Holding History

Financial Architects (New Jersey)’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-700	Closed	-$1K	–	1425
2019 Q1	$1K	Hold	700	–	–	﹤0.01%	1385
2018 Q4	$1K	Hold	700	–	–	﹤0.01%	1289
2018 Q3	$1K	Hold	700	–	–	﹤0.01%	1384
2018 Q2	$1K	Hold	700	–	–	﹤0.01%	1280
2018 Q1	$5K	Hold	700	–	–	﹤0.01%	1233
2017 Q4	$3K	Hold	700	–	–	﹤0.01%	1384
2017 Q3	$3K	Hold	700	–	–	﹤0.01%	1375
2017 Q2	$3K	Hold	700	–	–	﹤0.01%	1384
2017 Q1	$4K	Hold	700	–	–	﹤0.01%	1342
2016 Q4	$3K	Hold	700	–	–	﹤0.01%	1250
2016 Q3	$5K	Hold	700	–	–	﹤0.01%	1156
2016 Q2	$11K	Buy	+700	New	+$11.1K	﹤0.01%	955

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Financial Architects (New Jersey)'s FLNA Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Filana Therapeutics (FLNA) in Q2 2019, closing a stake of 700 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in FLNA in Q2 2016 and held it in 12 quarters. The position peaked at $11K in Q2 2016. 26 funds tracked by Wall St. Rank hold FLNA as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Filana Therapeutics position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 700 Filana Therapeutics shares in Q2 2019, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Filana Therapeutics in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Filana Therapeutics position peaked at $11K in Q2 2016.
26 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.